Tomohiro Higa - Aug 18, 2025 Form 4 Insider Report for Tenaya Therapeutics, Inc. (TNYA)

Role
SVP, Finance
Signature
/s/ Jennifer Drimmer Rokovich, Attorney-in-Fact
Stock symbol
TNYA
Transactions as of
Aug 18, 2025
Transactions value $
-$3,711
Form type
4
Date filed
8/18/2025, 09:00 PM
Previous filing
May 16, 2025
Next filing
Nov 17, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Higa Tomohiro SVP, Finance C/O TENAYA THERAPEUTICS, INC., 171 OYSTER POINT BLVD., 5TH FLOOR, SOUTH SAN FRANCISCO /s/ Jennifer Drimmer Rokovich, Attorney-in-Fact 2025-08-18 0002054280

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNYA Common Stock Sale -$655 -523 -0.53% $1.25 97.8K Aug 18, 2025 Direct F1, F2, F3
transaction TNYA Common Stock Sale -$898 -717 -0.73% $1.25 97.1K Aug 18, 2025 Direct F2, F4, F5
transaction TNYA Common Stock Sale -$2.16K -1.72K -1.77% $1.25 95.3K Aug 18, 2025 Direct F2, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023.
F2 Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.18 to $1.32. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 Includes 60,844 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
F4 Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024.
F5 Includes 58,907 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
F6 Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on January 24, 2025.
F7 Includes 54,220 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.